Enable sensitive mutation detection for quantifying TMB across various tumor indications.
Global industry-leading expertise and resources to help support high quality delivery of routine and complex bioanalytical and ADME projects for our customers.
ICON's proven site and patient recruitment paradigm bridges the gap between patients and clinical research sites.
Bringing the patient’s perspective into all phases of development.
Transform data into persuasive evidence to document the clinical, economic, and humanistic value of innovative drugs and devices before and after product approval and launch. Ready to learn how?
Medical and regulatory documentation developed by experienced medical writing teams plays a pivotal role in the success of a clinical research project.
Flex Advantage offers enhanced randomization, clinical supply management capabilities and enables the execution of adaptive clinical trials.
Executing efficient and compliant adaptive trials,
The DIA 2018 Global Annual Meeting is shaping up to be the Life Sciences Event of the Year! Download this year's Preliminary Program to learn why! Get the highlight reel of DIA 2018.
How a powerful forecasting and demand planning technology for managing the end-to-end clinical supply chain can quickly simulate the most common scenarios for each step of your study, create a study baseline and forecast randomization into different dosing groups.
|
|
|
|
|
|
|
|
|